An unusual native tricuspid valve endocarditis caused by Candida colliculosa

Clin Microbiol Infect. 2003 Apr;9(4):319-22. doi: 10.1046/j.1469-0691.2003.00511.x.

Abstract

Candida colliculosa, which grew in blood cultures of a 71-year-old retired man with fever of unknown origin that had lasted for 7 months, in conjunction with transthoracic echocardiography, demonstrating a 20-mm vegetation, superior to the tricuspid valve, herniating into the right atrial cavity. The finding led to the diagnosis of fungal endocarditis. Fluconazole, 600 mg daily, was commenced for 8 days; followed by amphotericin B, 1 mg/kg daily. On the fourth day of the amphotericin B treatment, the patient underwent replacement of the infected tricuspid valve. Even though the initial postoperative period was relatively uncomplicated, the patient died after a gross aspiration on the 67th day of his hospital stay, despite aggressive cardiovascular support and antimicrobial therapy. This is the first report of a native tricuspid valve fungal endocarditis due to C. colliculosa or Torulaspora delbrueckii, which is not known to be a human pathogen.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amphotericin B / pharmacology
  • Amphotericin B / therapeutic use
  • Candida / classification
  • Candida / isolation & purification
  • Candida / pathogenicity
  • Candidiasis / diagnosis*
  • Candidiasis / drug therapy
  • Candidiasis / microbiology
  • Endocarditis / diagnosis
  • Endocarditis / drug therapy
  • Endocarditis / microbiology*
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use
  • Humans
  • Male
  • Tricuspid Valve / microbiology*

Substances

  • Amphotericin B
  • Fluconazole